19-Iodocholesterol
19-Iodocholesterol | |
---|---|
(3S,8S,9S,10S,13R,14S,17R)-10-(iodomethyl)-13-methyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | |
Identifiers | |
CAS number | 37414-03-2 |
PubChem | 21150757 |
ChemSpider | 20086815 |
ATC code | V09 ,(131I) |
Jmol-3D images | {{#if:CC(C)CCC[C@@H](C)[C@H]3CC[C@H]2[C@@H]4C\C=C1\C[C@@H](O)CC[C@]1(CI)[C@H]4CC[C@@]23C|Image 1 |
| |
| |
Properties | |
Molecular formula | C27H45IO |
Molar mass | 512.55 g mol−1 |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
19-Iodocholesterol is a derivative of cholesterol with an iodine atom in the 19-position. When the iodine atom is a radioactive isotope (iodine-125 or iodine-131), it is used as an adrenal cortex radiocontrast agent for in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.[1]